MAPT and Alzheimer disease: While hyperphosphorylated tau is ubiquitinated in patients with AD [38,44] (Figure 1), indicating that pathological tau species may be successfully targeted for degradation, the accumulation of ubiquitinated tau species in those patients suggests dysfunction of either proteasomal or lysosomal degradation pathways contributes to NFT formation in disease.